AU2444399A - New use for pain management - Google Patents
New use for pain managementInfo
- Publication number
- AU2444399A AU2444399A AU24443/99A AU2444399A AU2444399A AU 2444399 A AU2444399 A AU 2444399A AU 24443/99 A AU24443/99 A AU 24443/99A AU 2444399 A AU2444399 A AU 2444399A AU 2444399 A AU2444399 A AU 2444399A
- Authority
- AU
- Australia
- Prior art keywords
- new use
- pain management
- pain
- muskuloskeletal
- ropivacaine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 abstract 1
- 208000000491 Tendinopathy Diseases 0.000 abstract 1
- 206010043255 Tendonitis Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960001549 ropivacaine Drugs 0.000 abstract 1
- 201000004415 tendinitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Adornments (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9800139A SE9800139D0 (sv) | 1998-01-21 | 1998-01-21 | New use |
| SE9800139 | 1998-01-21 | ||
| PCT/SE1999/000012 WO1999037301A1 (en) | 1998-01-21 | 1999-01-11 | New use for pain management |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2444399A true AU2444399A (en) | 1999-08-09 |
Family
ID=20409917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU24443/99A Abandoned AU2444399A (en) | 1998-01-21 | 1999-01-11 | New use for pain management |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6395291B1 (https=) |
| EP (1) | EP1054671B1 (https=) |
| JP (1) | JP4456754B2 (https=) |
| AT (1) | ATE228840T1 (https=) |
| AU (1) | AU2444399A (https=) |
| DE (1) | DE69904297T2 (https=) |
| DK (1) | DK1054671T3 (https=) |
| ES (1) | ES2189386T3 (https=) |
| PT (1) | PT1054671E (https=) |
| SE (1) | SE9800139D0 (https=) |
| WO (1) | WO1999037301A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200611217A (en) * | 2005-12-06 | 2006-04-01 | Shin Hwa Biotech Co Ltd | Human model for indexing nerve paths (locus) having corresponding relations and method for indexing |
| US8920843B2 (en) * | 2007-11-07 | 2014-12-30 | Svip5 Llc | Slow release of organic salts of local anesthetics for pain relief |
| US10111850B2 (en) * | 2015-12-01 | 2018-10-30 | Samuel Wilson | Ester and cholinesterase inhibitor in long-acting nerve block |
| CA2898933A1 (en) * | 2014-07-30 | 2016-01-30 | Grigory Karmy | Method for relieving chronic pain |
| US10751249B2 (en) * | 2017-11-26 | 2020-08-25 | Johnson Athletic Advantage LLC | Trigger point dry needling in motion and method of use |
| BE1026845B1 (nl) | 2018-12-07 | 2020-07-08 | Fagron Compounding Services Nv | Samenstelling voor gebruik in lokale infiltratie analgesie (LIA) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3379266D1 (en) | 1983-08-01 | 1989-04-06 | Astra Laekemedel Ab | L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same |
| SE451840B (sv) | 1986-01-03 | 1987-11-02 | Astra Laekemedel Ab | Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning |
| SE9401174D0 (sv) | 1994-04-07 | 1994-04-07 | Astra Ab | New combination |
| ATE481970T1 (de) | 1997-03-13 | 2010-10-15 | James N Campbell | Zusammensetzungen enthaltend capsaicin oder capsaicin analoge und ein anästhetikum |
-
1998
- 1998-01-21 SE SE9800139A patent/SE9800139D0/xx unknown
-
1999
- 1999-01-11 EP EP99903972A patent/EP1054671B1/en not_active Expired - Lifetime
- 1999-01-11 JP JP2000528283A patent/JP4456754B2/ja not_active Expired - Lifetime
- 1999-01-11 ES ES99903972T patent/ES2189386T3/es not_active Expired - Lifetime
- 1999-01-11 AT AT99903972T patent/ATE228840T1/de active
- 1999-01-11 WO PCT/SE1999/000012 patent/WO1999037301A1/en not_active Ceased
- 1999-01-11 DK DK99903972T patent/DK1054671T3/da active
- 1999-01-11 US US09/254,382 patent/US6395291B1/en not_active Expired - Lifetime
- 1999-01-11 PT PT99903972T patent/PT1054671E/pt unknown
- 1999-01-11 AU AU24443/99A patent/AU2444399A/en not_active Abandoned
- 1999-01-11 DE DE69904297T patent/DE69904297T2/de not_active Expired - Lifetime
-
2002
- 2002-04-24 US US10/128,664 patent/US6620423B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2189386T3 (es) | 2003-07-01 |
| US20020156101A1 (en) | 2002-10-24 |
| JP2002501021A (ja) | 2002-01-15 |
| EP1054671B1 (en) | 2002-12-04 |
| WO1999037301A1 (en) | 1999-07-29 |
| US6620423B2 (en) | 2003-09-16 |
| DE69904297T2 (de) | 2003-08-21 |
| US6395291B1 (en) | 2002-05-28 |
| EP1054671A1 (en) | 2000-11-29 |
| DE69904297D1 (de) | 2003-01-16 |
| JP4456754B2 (ja) | 2010-04-28 |
| DK1054671T3 (da) | 2003-02-24 |
| ATE228840T1 (de) | 2002-12-15 |
| PT1054671E (pt) | 2003-03-31 |
| SE9800139D0 (sv) | 1998-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ515567A (en) | Method for treating chronic pain using MEK inhibitors | |
| IL144294A0 (en) | P53 inhibitors and therapeutic use of the same | |
| MX9700886A (es) | Nuevas oxazolidinonas sustituidas. | |
| IL144643A0 (en) | Jak-3 inhibitors for treating allergic disorders | |
| TW200505434A (en) | Therapeutic treatment | |
| DK0703786T3 (da) | Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS | |
| YU82602A (sh) | Korišćenje il-18 inhibitora za lečenje i/ili prevenciju ateroskleroze | |
| SE9802208D0 (sv) | Novel compounds | |
| AU8736798A (en) | Use of cholinesterase inhibitors for treating attention deficit disorders | |
| GEP20063828B (en) | Methods for Treating or Preventing Skin Disorders Using CD2-Binding Agents | |
| AU2001246600A1 (en) | Use of comt inhibitors as analgesics | |
| PT1030667E (pt) | Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono | |
| AU2444399A (en) | New use for pain management | |
| NZ513851A (en) | Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders | |
| DE59709922D1 (de) | Pflaster zur transdermalen anwendung von pergolid | |
| IL138594A0 (en) | Use of protease inhibitors for treating skin wounds | |
| GB9626472D0 (en) | New use of comt inhibitors | |
| IL139144A0 (en) | Mycobacterial inhibitors | |
| ATE262362T1 (de) | Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung | |
| AU4179497A (en) | Use of PKC inhibitors for the manufacture of a medicament for the treatment f AIDS | |
| AP2000001907A0 (en) | Crystalline form of paroxetine. | |
| GR1004434B (el) | Χρησηατουαdiclofenacαhααποδεκτωνααλατωνααυτουαγιαατηνααντιμετωπισηατωναεγκαυματων | |
| GB9908838D0 (en) | Fibroblast inhibitor | |
| AU2001276323A1 (en) | Use of n-oleoylethanolamine for treating psoriasis | |
| AU3145400A (en) | Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |